SAMLUTA 40MG CAPS

Product Description

• Active Ingredient: Enzalutamide 40mg.
• Medical Class: Androgen receptor inhibitor/antiandrogen.
• Primary Use: Treatment of various stages of prostate cancer, including metastatic castration-resistant, non-metastatic castration-resistant, and metastatic hormone-sensitive prostate cancer. It is used in adult males, especially when the cancer no longer responds to standard hormone therapy or surgical interventions.
• Mechanism of Action: Most prostate cancers need testosterone to grow. Enzalutamide prevents testosterone from binding to cancer cells' androgen receptors, which slows the growth of the cancer and may cause tumors to shrink.
• Dosage: The typical daily dose is 160mg (four 40mg capsules), taken orally once a day with or without food, or as directed by a doctor.
• Important Precautions:
  • It should be used under proper medical guidance and is available by prescription only.
  • It is not recommended for women, especially during pregnancy or breastfeeding, due to the risk of harm to an unborn baby.
  • Men using this medication must use effective contraception during treatment and for at least three months after the final dose.
  • It may increase the risk of seizures, so patients with a history of seizures, brain injury, or stroke require extra caution.
  • Regular monitoring of blood pressure, liver function, and blood cell count is essential during treatment.